Indonesia vs Mozambique: Cause of death, by non-communicable diseases, ages 60+, male
Indonesia
51.7%
in 2021
Mozambique
49.5%
in 2021
Indonesia rank
166th
Mozambique rank
168th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Indonesia
- Mozambique
How they compare
Indonesia currently reports 51.7% against 49.5% in Mozambique, a difference of 2.2%.
Across all 6 years both countries report, Indonesia has been ahead every year.
Indonesia ranks 166th and Mozambique ranks 168th of 185 countries.
Indonesia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Indonesia | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.2% | 50.0% | 26.3% | Indonesia |
| 2010s | 82.8% | 61.9% | 20.8% | Indonesia |
| 2020s | 59.8% | 56.9% | 2.9% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Indonesia or Mozambique?
- Indonesia, at 51.7% against 49.5% in Mozambique as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Indonesia and Mozambique?
- 2.2%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Mozambique?
- 6 years are reported by both, from 2000 to 2021.
- How do Indonesia and Mozambique rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Indonesia ranks 166th and Mozambique ranks 168th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.